Skip to content

Exposure and Response Prevention With Behavioral- Versus Cognitive Therapy Rationale in Obsessive Compulsive Disorder

Exposure and Response Prevention (ERP) With Behavioral- Versus Cognitive Therapy Rationale in the Treatment of OCD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00184262
Enrollment
35
Registered
2005-09-16
Start date
2003-01-31
Completion date
2006-12-31
Last updated
2012-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Brief summary

The aim of the study is to determine whether exposure and response prevention (ERP) is more effective when patients are presented with a behavioral therapy versus cognitive therapy rationale in the treatment of obsessive-compulsive disorder (OCD).

Detailed description

The aim of the study is to determine whether exposure and response prevention (ERP) is more effective when patients are presented with a behavioral therapy versus cognitive therapy rationale in the treatment of obsessive-compulsive disorder OCD. A randomized controlled trial including patients with OCD. 50 patients will receive 15 ERP sessions in 3 months.

Interventions

BEHAVIORALERP cognitive therapy

15 exposure and response prevention (ERP) sessions in 3 months with a cognitive therapy rationale

BEHAVIORALERP behavioral therapy

15 exposure and response prevention (ERP) sessions in 3 months with a behavioral therapy rationale

Sponsors

Norwegian Foundation for Health and Rehabilitation
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Obsessive-compulsive disorder

Exclusion criteria

* active thought disorder, uncontrolled bipolar disorder, mental retardation, organic mental disorder, initiation or change in medication three months prior to inclusion in the study

Design outcomes

Primary

MeasureTime frame
scores on Y-BOCS and SCID-I3 months

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026